These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 39010216)

  • 1. Assessment of the Safety of Exposure to Cefcapene Pivoxil during the First Trimester of Pregnancy: A Prospective Cohort Study in Japan.
    Miki Y; Koga Y; Taogoshi T; Itamura R; Yokooji T; Hishinuma K; Yakuwa N; Goto M; Murashima A; Matsuo H
    Biol Pharm Bull; 2024; 47(7):1301-1306. PubMed ID: 39010216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes after first-trimester exposure to fluoroquinolones: Findings based on an integrated database from two Japanese institutions.
    Goto M; Anzai T; Yamane R; Yakuwa N; Takahashi K; Murashima A
    Congenit Anom (Kyoto); 2024 Sep; 64(5):199-206. PubMed ID: 38936845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study.
    Chuang CH; Doyle P; Wang JD; Chang PJ; Lai JN; Chen PC
    Drug Saf; 2006; 29(6):537-48. PubMed ID: 16752935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero exposure to antibiotics and risk of congenital malformations: a population-based study.
    Damkier P; Brønniche LMS; Korch-Frandsen JFB; Broe A
    Am J Obstet Gynecol; 2019 Dec; 221(6):648.e1-648.e15. PubMed ID: 31260651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy.
    Daniel S; Doron M; Fishman B; Koren G; Lunenfeld E; Levy A
    Br J Clin Pharmacol; 2019 Dec; 85(12):2856-2863. PubMed ID: 31486528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy.
    Usuda M; Jwa SC; Goto M; Kobayashi M; Nagano H; Yakuwa N; Yamane R; Murashima A; Makabe H
    Congenit Anom (Kyoto); 2024 May; 64(3):91-98. PubMed ID: 38445786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.
    Fan H; Gilbert R; O'Callaghan F; Li L
    BMJ; 2020 Feb; 368():m331. PubMed ID: 32075790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study.
    Rotem R; Fishman B; Daniel S; Koren G; Lunenfeld E; Levy A
    BJOG; 2018 Nov; 125(12):1550-1556. PubMed ID: 29790255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
    Daniel S; Matok I; Gorodischer R; Koren G; Uziel E; Wiznitzer A; Levy A
    J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor penetration of cefcapene into aqueous humor after oral administration of cefcapene pivoxil to patients undergoing cataract surgery.
    Okamoto K; Asano S; Yamamoto T; Toyono T; Yamaguchi R; Okada Y; Okugawa S; Suzuki H; Moriya K; Aihara M
    J Infect Chemother; 2020 Feb; 26(2):312-315. PubMed ID: 31481306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive skin prick test to cefcapene pivoxil hydrochloride hydrate: a case report.
    Yamazato S; Nakai N; Katoh N
    Allergol Int; 2013 Jun; 62(2):263-4. PubMed ID: 23612491
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan.
    Hatakeyama S; Goto M; Yamamoto A; Ogura J; Watanabe N; Tsutsumi S; Yakuwa N; Yamane R; Nagase S; Takahashi K; Kosaki R; Murashima A; Yamaguchi H
    Congenit Anom (Kyoto); 2022 Jul; 62(4):161-168. PubMed ID: 35538631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study.
    Muanda FT; Sheehy O; Bérard A
    Br J Clin Pharmacol; 2017 Nov; 83(11):2557-2571. PubMed ID: 28722171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
    Goldberg O; Koren G; Landau D; Lunenfeld E; Matok I; Levy A
    J Clin Pharmacol; 2013 Sep; 53(9):991-5. PubMed ID: 23873250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.
    Thomseth V; Cejvanovic V; Jimenez-Solem E; Poulsen HE; Utheim TP; Andersen JT
    Acta Ophthalmol; 2019 Aug; 97(5):505-509. PubMed ID: 30479070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.
    Bar-Oz B; Weber-Schoendorfer C; Berlin M; Clementi M; Di Gianantonio E; de Vries L; De Santis M; Merlob P; Stahl B; Eleftheriou G; Maňáková E; Hubičková-Heringová L; Youngster I; Berkovitch M
    Drug Saf; 2012 Jul; 35(7):589-98. PubMed ID: 22702640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy Outcomes With Exposure to Second-Generation Antipsychotics During the First Trimester.
    Yakuwa N; Takahashi K; Anzai T; Ito N; Goto M; Koinuma S; Uno C; Suzuki T; Watanabe O; Yamatani A; Murashima A
    J Clin Psychiatry; 2022 Jun; 83(4):. PubMed ID: 35687862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.